CS
NVCN

Candriam SCA’s Neovasc Inc. NVCN Stock Holding History

Candriam SCA’s Portfolio NVCN Stock Details NVCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4
Closed -$141K – 754
2017
Q2 		$141K Hold
4
– – ﹤0.01% 698
2017
Q1 		$157K Hold
4
– – ﹤0.01% 684
2016
Q4 		$176K Hold
4
– – ﹤0.01% 661
2016
Q3 		$52K Hold
4
– – ﹤0.01% 655
2016
Q2 		$53K Hold
4
– – ﹤0.01% 653
2016
Q1 		$429K Hold
4
– – 0.01% 569
2015
Q4 		$459K Buy
4
+1
+33% +$115K 0.01% 471
2015
Q3 		$410K Hold
3
– – 0.01% 551
2015
Q2 		$527K Hold
3
– – 0.01% 529
2015
Q1 		$621K Buy
3
+2
+200% +$437K 0.01% 520
2014
Q4 		$199K Buy
+1
New +$151K ﹤0.01% 614

Other funds holding NVCN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Candriam SCA's NVCN Position: Q3 2017 in Review

Candriam SCA sold out of Neovasc Inc. (NVCN) in Q3 2017, closing a stake of 4 shares — an estimated $141K sold.

Candriam SCA first reported a position in NVCN in Q4 2014 and held it in 11 quarters. The position peaked at $621K in Q1 2015. 10 funds tracked by Wall St. Rank hold NVCN as of Q3 2017.

  • Candriam SCA reported no remaining Neovasc Inc. position as of Q3 2017 after selling out during the quarter.
  • Candriam SCA sold 4 Neovasc Inc. shares in Q3 2017, an estimated $141K.
  • Candriam SCA first reported a position in Neovasc Inc. in Q4 2014 and held it in 11 quarters.
  • Candriam SCA's Neovasc Inc. position peaked at $621K in Q1 2015.
  • 10 funds tracked by Wall St. Rank held Neovasc Inc. as of Q3 2017.

Based on Candriam SCA's 13F filing for Q3 2017, filed 3 Nov 2017.